These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 10080425)

  • 41. [Management of hypertensive patients with left ventricular hypertrophy].
    Ambrosioni E
    Presse Med; 2002 Oct; 31 Spec No 2():S13-6. PubMed ID: 12355999
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of the effects of amlodipine and diltiazem on 24-hour blood pressure, plasma catecholamines, and left ventricular mass.
    Leenen FH; Fourney A
    Am J Cardiol; 1996 Jul; 78(2):203-7. PubMed ID: 8712143
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial.
    Devereux RB; Dahlöf B; Gerdts E; Boman K; Nieminen MS; Papademetriou V; Rokkedal J; Harris KE; Edelman JM; Wachtell K
    Circulation; 2004 Sep; 110(11):1456-62. PubMed ID: 15326072
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Value of rilmenidine therapy and its combination with perindopril on blood pressure and left ventricular hypertrophy in patients with essential hypertension (VERITAS).
    Farsang C; Lengyel M; Borbás S; Zorándi A; Dienes BS;
    Curr Med Res Opin; 2003; 19(3):205-17. PubMed ID: 12803735
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Is left ventricular systolic dysfunction in hypertensive patients with heart failure normalized by long-term antihypertensive therapy?
    Hamada M; Ohtani T; Suzuki M; Lin M; Kobayashi T; Okayama H; Takezaki M; Hashida K; Abe M; Matsuoka H
    J Cardiol; 1993; 23(2):165-75. PubMed ID: 8176628
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevention of increases in blood pressure and left ventricular mass and remodeling of resistance arteries in young New Zealand genetically hypertensive rats: the effects of chronic treatment with valsartan, enalapril and felodipine.
    Ledingham JM; Phelan EL; Cross MA; Laverty R
    J Vasc Res; 2000; 37(2):134-45. PubMed ID: 10754398
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of enalapril in cats with pressure overload-induced left ventricular hypertrophy.
    Ishikawa Y; Uechi M; Hori Y; Takashi Ebisawa ; Yamano S; Enomoto Y; Jun Ugai
    J Feline Med Surg; 2007 Feb; 9(1):29-35. PubMed ID: 16934512
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term effects of benazepril on ambulatory blood pressure, left ventricular mass, diastolic filling and aortic flow in essential hypertension.
    Porcellati C; Verdecchia P; Schillaci G; Boldrini F; Motolese M
    Int J Clin Pharmacol Ther Toxicol; 1991 May; 29(5):187-97. PubMed ID: 1830037
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acute and subacute haemodynamic effects of enalapril. Non-invasive studies of a new converting enzyme inhibitor for antihypertensive treatment.
    Wikstrand J; Herlitz H; Berglund G
    Scand J Urol Nephrol Suppl; 1984; 79():81-5. PubMed ID: 6089322
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of late-onset and long-term captopril and nifedipine treatment in aged spontaneously hypertensive rats: Echocardiographic studies.
    Zimmer J; Hawlitschek C; Rabald S; Hagendorff A; Zimmer HG; Rassler B
    Hypertens Res; 2015 Nov; 38(11):716-22. PubMed ID: 26178152
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Angiotensin-converting enzyme inhibitors influence left ventricular mass and function independently of the antihypertensive effect.
    Grandi AM; Laurita E; Solbiati F; Marchesi C; Maresca AM; Nicolini E; Guasti L; Venco A
    J Cardiovasc Pharmacol; 2006 Nov; 48(5):207-11. PubMed ID: 17110802
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reversal of left ventricular hypertrophy with angiotensin converting enzyme inhibition in hypertensive patients with autosomal dominant polycystic kidney disease.
    Ecder T; Edelstein CL; Chapman AB; Johnson AM; Tison L; Gill EA; Brosnahan GM; Schrier RW
    Nephrol Dial Transplant; 1999 May; 14(5):1113-6. PubMed ID: 10344347
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Discrepant regulation of QT (QTc) interval duration by calcium channel blockade and angiotensin converting enzyme inhibition in experimental hypertension.
    Klimas J; Vaja V; Vercinska M; Kyselovic J; Krenek P
    Basic Clin Pharmacol Toxicol; 2012 Oct; 111(4):279-88. PubMed ID: 22626243
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of blood pressure response to the combination of enalapril (single dose) and diltiazem ER (four different doses) in systemic hypertension.
    Applegate WB; Cohen JD; Wolfson P; Davis A; Green S
    Am J Cardiol; 1996 Jul; 78(1):51-5. PubMed ID: 8712118
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Changes in left ventricular mass and volumes in patients receiving angiotensin-converting enzyme inhibitor therapy for left ventricular dysfunction after Q-wave myocardial infarction.
    Foster RE; Johnson DB; Barilla F; Blackwell GG; Orr R; Roney M; Stanley AW; Pohost GM; Dell'Italia LJ
    Am Heart J; 1998 Aug; 136(2):269-75. PubMed ID: 9704689
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Regression of left ventricular hypertrophy and improvement of its diastolic function in patients with arterial hypertension under influence of antihypertensive therapy].
    Borzova NV; Gorbachenkov AA
    Kardiologiia; 2008; 48(6):44-50. PubMed ID: 18729836
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enalapril does not improve left ventricular diastolic dysfunction in young and mild hypertensives without concomitant hypertrophy.
    Chang NC; Lai ZY; Wang TC
    Am J Hypertens; 1996 Sep; 9(9):909-14. PubMed ID: 8879348
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The clinical and hemodynamic efficacy of telmisartan and enalapril in the treatment of arterial hypertension in patients with type 2 diabetes mellitus].
    Tatarchenko IP; Pozdniakova NV; Mordovina AG; Morozova OI; Zaĭtseva AV
    Ter Arkh; 2009; 81(12):11-5. PubMed ID: 20481040
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Blood pressure-lowering efficacy of amiloride versus enalapril as add-on drugs in patients with uncontrolled blood pressure receiving hydrochlorothiazide.
    Guerrero P; Fuchs FD; Moreira LM; Martins VM; Bertoluci C; Fuchs SC; Gus M
    Clin Exp Hypertens; 2008 Oct; 30(7):553-64. PubMed ID: 18855259
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of Renal Sympathetic Denervation on Left Ventricular Structure and Function at 1-Year Follow-Up.
    de Sousa Almeida M; de Araújo Gonçalves P; Branco P; Mesquita J; Carvalho MS; Dores H; Silva Sousa H; Gaspar A; Horta E; Aleixo A; Neuparth N; Mendes M; Andrade MJ
    PLoS One; 2016; 11(3):e0149855. PubMed ID: 26934735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.